Catalyst Pharmaceuticals Inc

+0.35 (+2.14%)
7:57:25 PM EDT: $16.80 +0.08 (+0.48%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.77B
Current PE21.26
Forward PE 11.07
2yr Forward PE 8.94
See more stats
Estimates Current Quarter
Revenue$81.62 Million
Adjusted EPS$0.32
See more estimates
10-Day MA$16.15
50-Day MA$15.88
200-Day MA$14.02
See more pivots

Catalyst Pharmaceuticals Inc Stock, NASDAQ:CPRX

355 Alhambra Circle, Suite 801, Coral Gables, Florida 33134
United States of America
Phone: +1.305.420.3200
Number of Employees: 82


Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing and commercializing novel medicines for patients living with rare diseases including Lambert-Eaton myasthenic syndrome, congenital myasthenic syndromes, MuSK antibody positive myasthenia gravis, spinal muscular atrophy type 3, and infantile spasms. The company was founded by Huckel E. Hubert and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.